Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring ...

The Mid-South health system identified over twice as many incidental pulmonary nodules, half of which were in a higher-risk ...

For years, many healthcare executives treated claim denials as a back-office irritation—a revenue problem to be delegated, ...

New French guidelines reshape care for urinary tract infections in men, dropping urine dipsticks, recognizing male cystitis, ...

Medecision, a subsidiary of Health Care Service Corporation (HCSC), is trusted by leading health organizations , health plans , third-party administrators, and government entities. Its flagship ...

Discover why Day One Biopharmaceuticals, Inc. is surging with Ojemda's growth, strategic deals, and key 2026 catalysts. Click ...

Preliminary findings in a rapid inquiry into NHS maternity services have recently been delivered. This is ahead of full ...

Kalaris Therapeutics, Inc. reported improved Q3'25 results, with a net loss of $11.9M and $77M in cash. Click here to read why KLRS stock is a Buy.

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid ...

CHS is tackling debt and redefining itself as a healthcare company by focusing on quality, operational efficiency, ...

Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview Insulet’s new study, officially titled “Safety and Efficacy of ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...